Anavex Life Sciences Corp (AVXL)

[ChrisMissing]

This r & d session of course will be big. I presume we will hear finally a deep dive into each indication and maybe we will get to hear the story about “ when we tell you why we did what we did you will then understand “. Or that question should be asked by someone. This to me is a transformational meeting. We should be getting something new for each indication. If not why do it. I’ll throw out a few potentials. PDD Ole data, maybe some Alzheimer’s ole data, new indication(s) update, start of p2 371 ftd, start of fragile X trial.

Feel free to add to this list. I think this is going to be huge.